• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

标准护理单元中 SARS-CoV-2 肺炎患者的深静脉血栓形成：探索冰山一角。

Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg.

机构信息

Department of Medicine, University of Verona, Verona, Italy.

Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

出版信息

Thromb Res. 2020 Oct;194:216-219. doi: 10.1016/j.thromres.2020.08.008. Epub 2020 Aug 6.

DOI:10.1016/j.thromres.2020.08.008
PMID:33074107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7409796/
Abstract

• An association between COVID-19 and venous thromboembolism (VTE) is now recognized. • The prevalence of VTE is high in COVID-19 patients hospitalized in standard care units. • The prevalence of VTE is high even though thromboprophylaxis and in patients estimated at low risk. • A high index of suspicion for VTE is crucial in patients with SARS-CoV-2 infection.

摘要

• COVID-19 与静脉血栓栓塞症（VTE）之间存在关联，这一点现在已经得到了认可。 • 在标准护理病房住院的 COVID-19 患者中，VTE 的患病率很高。 • 即使在接受预防性抗血栓治疗的患者以及低危患者中，VTE 的患病率也很高。 • 对 SARS-CoV-2 感染患者的 VTE 应保持高度怀疑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefe/7409796/2b078cf1817b/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefe/7409796/2b078cf1817b/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cefe/7409796/2b078cf1817b/ga1_lrg.jpg

相似文献

1
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg.标准护理单元中 SARS-CoV-2 肺炎患者的深静脉血栓形成：探索冰山一角。
Thromb Res. 2020 Oct;194:216-219. doi: 10.1016/j.thromres.2020.08.008. Epub 2020 Aug 6.
2
SARS-CoV-2 shedding and infectivity.严重急性呼吸综合征冠状病毒2型的病毒脱落与传染性。
Lancet. 2020 Apr 25;395(10233):1339-1340. doi: 10.1016/S0140-6736(20)30868-0. Epub 2020 Apr 15.
3
Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.住院的新冠肺炎患者与静脉血栓栓塞：一场完美风暴。
Circulation. 2020 Jul 14;142(2):129-132. doi: 10.1161/CIRCULATIONAHA.120.048020. Epub 2020 Jul 13.
4
Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity.未来严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗初始短缺时的分配标准及全球免疫所需措施。
Vaccine. 2020 Jul 22;38(34):5396-5397. doi: 10.1016/j.vaccine.2020.06.058. Epub 2020 Jun 23.
5
Atypical Deep Cerebral Vein Thrombosis with Hemorrhagic Venous Infarction in a Patient Positive for COVID-19.COVID-19 阳性患者伴出血性静脉梗死的非典型深部脑静脉血栓形成。
AJNR Am J Neuroradiol. 2020 Aug;41(8):1377-1379. doi: 10.3174/ajnr.A6642. Epub 2020 Jun 18.
6
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and the Upper Limb Deep Vein Thrombosis Risk.严重急性呼吸综合征冠状病毒2感染与上肢深静脉血栓形成风险
Ann Vasc Surg. 2020 Jul;66:11-13. doi: 10.1016/j.avsg.2020.04.037. Epub 2020 Apr 23.
7
Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?新冠病毒时代的炎症性肠病与生物治疗。为何不呢？
Inflamm Bowel Dis. 2020 Jun 18;26(7):e71. doi: 10.1093/ibd/izaa110.
8
SARS-CoV-2 and influenza virus co-infection.严重急性呼吸综合征冠状病毒2型与流感病毒合并感染
Lancet. 2020 May 16;395(10236):e84. doi: 10.1016/S0140-6736(20)31052-7. Epub 2020 May 5.
9
Asymptomatic SARS-CoV-2 infection: the tip or the iceberg?无症状的新冠病毒感染：是冰山一角还是整座冰山？
Thorax. 2020 Aug;75(8):621-622. doi: 10.1136/thoraxjnl-2020-215337. Epub 2020 Jun 24.
10
Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China.2019冠状病毒病（COVID-19）：中国以外地区的重症监护视角
Anaesth Crit Care Pain Med. 2020 Apr;39(2):167-169. doi: 10.1016/j.accpm.2020.03.001. Epub 2020 Mar 3.

引用本文的文献

1
Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis.因新冠肺炎住院患者静脉血栓栓塞症的临床特征及预后：系统评价与荟萃分析
Thromb Update. 2021;2:100037. doi: 10.1016/j.tru.2021.100037. Epub 2021 Mar 19.
2
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID-19 associated with mortality: An updated review.凝血功能障碍和血栓栓塞事件是 COVID-19 相关死亡率的发病机制：最新综述。
J Clin Lab Anal. 2023 Jun;37(11-12):e24941. doi: 10.1002/jcla.24941. Epub 2023 Jul 11.
3
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis.

本文引用的文献

1
Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.住院的新冠肺炎患者与静脉血栓栓塞：一场完美风暴。
Circulation. 2020 Jul 14;142(2):129-132. doi: 10.1161/CIRCULATIONAHA.120.048020. Epub 2020 Jul 13.
2
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
3
Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan.
严重急性呼吸综合征冠状病毒2型肺炎患者血浆中活化因子VII-抗凝血酶复合物水平升高表明组织因子表达增加：与新型冠状病毒肺炎血栓形成倾向的潜在联系。
Diagnostics (Basel). 2022 Nov 14;12(11):2792. doi: 10.3390/diagnostics12112792.
4
Characterizing Thrombotic Complication Risk Factors Associated With COVID-19 via Heterogeneous Patient Data: Retrospective Observational Study.通过异质患者数据对 COVID-19 相关血栓并发症风险因素进行特征描述：回顾性观察性研究。
J Med Internet Res. 2022 Oct 21;24(10):e35860. doi: 10.2196/35860.
5
Hindrance of the Proteolytic Activity of Neutrophil-Derived Serine Proteases by Serine Protease Inhibitors as a Management of Cardiovascular Diseases and Chronic Inflammation.丝氨酸蛋白酶抑制剂对中性粒细胞衍生丝氨酸蛋白酶蛋白水解活性的阻碍作用在心血管疾病和慢性炎症管理中的应用
Front Chem. 2021 Nov 15;9:784003. doi: 10.3389/fchem.2021.784003. eCollection 2021.
6
Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19.血管紧张素受体阻滞剂和血管紧张素转换酶抑制剂对新型冠状病毒肺炎的影响。
World J Clin Cases. 2021 Jul 16;9(20):5462-5469. doi: 10.12998/wjcc.v9.i20.5462.
7
Systematic screening for a proximal DVT in COVID-19 hospitalized patients: Results of a comparative study.对 COVID-19 住院患者进行近端深静脉血栓形成的系统筛查：一项对比研究的结果。
J Med Vasc. 2021 Jul;46(4):163-170. doi: 10.1016/j.jdmv.2021.05.003. Epub 2021 May 14.
8
Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19.COVID-19 住院患者入院前抗血栓治疗对疾病严重程度和死亡率的影响。
J Thromb Thrombolysis. 2022 Jan;53(1):96-102. doi: 10.1007/s11239-021-02507-2. Epub 2021 Jun 17.
9
Venous thromboembolism in COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎相关静脉血栓栓塞症：系统评价和荟萃分析。
Vasc Med. 2021 Aug;26(4):415-425. doi: 10.1177/1358863X21995566. Epub 2021 Apr 4.
10
COVID-19 in thrombosis research: An editorial perspective.血栓形成研究中的新冠病毒病：编辑视角
Thromb Res. 2021 May;201:147-150. doi: 10.1016/j.thromres.2021.03.011. Epub 2021 Mar 24.
武汉48例重症新型冠状病毒肺炎患者下肢深静脉血栓形成的极高发生率
Circulation. 2020 Jul 14;142(2):181-183. doi: 10.1161/CIRCULATIONAHA.120.047407. Epub 2020 May 15.
4
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?新冠病毒感染中的肺栓塞或肺血栓形成？使用高剂量肝素进行血栓预防的建议是否合理？
Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.
5
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
6
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.COVID-19 相关严重高凝状态与急性呼吸衰竭入住重症监护病房患者。
Thromb Haemost. 2020 Jun;120(6):998-1000. doi: 10.1055/s-0040-1710018. Epub 2020 Apr 21.
7
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病：预防、抗栓治疗与随访的相关问题：美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
8
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.入院时 D-二聚体水平预测 COVID-19 患者住院死亡率。
J Thromb Haemost. 2020 Jun;18(6):1324-1329. doi: 10.1111/jth.14859.
9
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
10
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.新型冠状病毒肺炎重型患者静脉血栓栓塞症发病情况。
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.